Elisha Roberson
Impact in
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
- Glaucoma and retinal disorders
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- A. BowcockJ. William HarbourLori A. WorleyMichael D. OnkenLi CaoShenghui DuanCynthia HelmsKatie A. Matatall
- Journals
- Frontiers in Immunology (2 papers)European Journal of Human Genetics (2 papers)Nature Microbiology (2 papers)Nature Genetics (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesEgyptUnited Kingdom
In The Last Decade
Elisha Roberson
28 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Ophthalmology 1.0k
- Immunology 838
- Dermatology 258
- Oncology 590
- Molecular Biology 1.4k
Countries citing papers authored by Elisha Roberson
This map shows the geographic impact of Elisha Roberson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisha Roberson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisha Roberson more than expected).
Fields of papers citing papers by Elisha Roberson
This network shows the impact of papers produced by Elisha Roberson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisha Roberson. The network helps show where Elisha Roberson may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elisha Roberson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 38 | |
| 3 | 2022 | 18 | |
| 4 | 2019 | 16 | |
| 5 | 2019 | 29 | |
| 6 | 2019 | 5 | |
| 7 | 2018 | 4 | |
| 8 | 2016 | 75 | |
| 9 | 2015 | 2 | |
| 10 | Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma Hit paper breakdown → | 2013 | 374 |
| 11 | 2012 | 288 | |
| 12 | 2012 | 6 | |
| 13 | 2011 | 65 | |
| 14 | 2011 | 127 | |
| 15 | 2010 | 44 | |
| 16 | 2010 | 189 | |
| 17 | Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas Hit paper breakdown → | 2010 | 1024 |
| 18 | 2009 | 6 | |
| 19 | 2009 | 30 | |
| 20 | 2008 | 232 |
About Elisha Roberson
Elisha Roberson is a scholar working on Ophthalmology, Biological Psychiatry, Dermatology, Immunology and Genetics, having authored 29 papers that have together received 2.8k indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (5 papers), Genetic Syndromes and Imprinting (3 papers), CRISPR and Genetic Engineering (3 papers), Genetic Associations and Epidemiology (3 papers), Retinal Development and Disorders (3 papers), Virus-based gene therapy research (2 papers), Genomics and Rare Diseases (2 papers) and Immune responses and vaccinations (2 papers). The work is most often cited by research in Ophthalmology (1.0k citations), Immunology (838 citations), Dermatology (258 citations), Oncology (590 citations) and Molecular Biology (1.4k citations). Elisha Roberson has collaborated with scholars based in United States, Egypt and United Kingdom. Frequent co-authors include A. Bowcock, J. William Harbour, Lori A. Worley, Michael D. Onken, Li Cao, Shenghui Duan, Cynthia Helms, Katie A. Matatall, Hima Anbunathan and Jonathan Pevsner. Their work appears in journals such as Frontiers in Immunology, European Journal of Human Genetics, Nature Microbiology, Nature Genetics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.